Matches in SemOpenAlex for { <https://semopenalex.org/work/W2407507636> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2407507636 endingPage "100" @default.
- W2407507636 startingPage "S12" @default.
- W2407507636 abstract "The goal of this National Cancer Institute-sponsored phase I trial is to determine the feasibility, toxicity, and pharmacokinetics of continuous-infusion (24 hr/d, 7 d/wk, 7 weeks total) intravenous paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) when combined with standard, curative-intent radiation therapy (RT) for previously untreated, locally advanced non-small cell lung cancers. Eligible patients have locally advanced (T4NXM0 or TXN2-3M0) non-small cell cancer ineligible for potentially curative surgical resection, a good performance status, adequate hematologic, hepatic, and renal functions, and no distant metastases. All patients receive a total tumor dose of 64.8 Gy megavoltage RT in 7 weeks at 1.8 Gy once daily, 5 d/wk. Paclitaxel is delivered by continuous intravenous infusion starting 48 hours before RT and continuing for its duration. The dose of paclitaxel is escalated in cohorts of three patients in a standard phase I design. To date, 16 patients have entered the trial, and 15 are evaluable for toxicity in this ongoing study. Paclitaxel dose is currently at a 6.5 mg/m2/d dose level, with no dose-limiting toxicity recorded thus far. One patient at the highest dose level has had grade 2 pneumonitis. With the exception of anemia, toxicities are those that would be expected from RT alone. A slowly progressive normocytic anemia with no renal dysfunction was found to be associated with an acquired hypoerythropoietin state. These findings indicate that this therapy is feasible and well tolerated through current dose levels, with no dose-limiting toxicity. Dose escalation is ongoing." @default.
- W2407507636 created "2016-06-24" @default.
- W2407507636 creator A5014159088 @default.
- W2407507636 creator A5031390646 @default.
- W2407507636 creator A5038267261 @default.
- W2407507636 creator A5038782869 @default.
- W2407507636 creator A5044373932 @default.
- W2407507636 creator A5045920008 @default.
- W2407507636 creator A5054690257 @default.
- W2407507636 creator A5059166265 @default.
- W2407507636 creator A5059652753 @default.
- W2407507636 creator A5070738461 @default.
- W2407507636 date "1997-08-01" @default.
- W2407507636 modified "2023-09-26" @default.
- W2407507636 title "Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study." @default.
- W2407507636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9331130" @default.
- W2407507636 hasPublicationYear "1997" @default.
- W2407507636 type Work @default.
- W2407507636 sameAs 2407507636 @default.
- W2407507636 citedByCount "6" @default.
- W2407507636 crossrefType "journal-article" @default.
- W2407507636 hasAuthorship W2407507636A5014159088 @default.
- W2407507636 hasAuthorship W2407507636A5031390646 @default.
- W2407507636 hasAuthorship W2407507636A5038267261 @default.
- W2407507636 hasAuthorship W2407507636A5038782869 @default.
- W2407507636 hasAuthorship W2407507636A5044373932 @default.
- W2407507636 hasAuthorship W2407507636A5045920008 @default.
- W2407507636 hasAuthorship W2407507636A5054690257 @default.
- W2407507636 hasAuthorship W2407507636A5059166265 @default.
- W2407507636 hasAuthorship W2407507636A5059652753 @default.
- W2407507636 hasAuthorship W2407507636A5070738461 @default.
- W2407507636 hasConcept C112705442 @default.
- W2407507636 hasConcept C121608353 @default.
- W2407507636 hasConcept C126322002 @default.
- W2407507636 hasConcept C126894567 @default.
- W2407507636 hasConcept C141071460 @default.
- W2407507636 hasConcept C143998085 @default.
- W2407507636 hasConcept C2776256026 @default.
- W2407507636 hasConcept C2776694085 @default.
- W2407507636 hasConcept C2777292972 @default.
- W2407507636 hasConcept C2777714996 @default.
- W2407507636 hasConcept C2778248108 @default.
- W2407507636 hasConcept C2779524853 @default.
- W2407507636 hasConcept C29730261 @default.
- W2407507636 hasConcept C31760486 @default.
- W2407507636 hasConcept C509974204 @default.
- W2407507636 hasConcept C71924100 @default.
- W2407507636 hasConceptScore W2407507636C112705442 @default.
- W2407507636 hasConceptScore W2407507636C121608353 @default.
- W2407507636 hasConceptScore W2407507636C126322002 @default.
- W2407507636 hasConceptScore W2407507636C126894567 @default.
- W2407507636 hasConceptScore W2407507636C141071460 @default.
- W2407507636 hasConceptScore W2407507636C143998085 @default.
- W2407507636 hasConceptScore W2407507636C2776256026 @default.
- W2407507636 hasConceptScore W2407507636C2776694085 @default.
- W2407507636 hasConceptScore W2407507636C2777292972 @default.
- W2407507636 hasConceptScore W2407507636C2777714996 @default.
- W2407507636 hasConceptScore W2407507636C2778248108 @default.
- W2407507636 hasConceptScore W2407507636C2779524853 @default.
- W2407507636 hasConceptScore W2407507636C29730261 @default.
- W2407507636 hasConceptScore W2407507636C31760486 @default.
- W2407507636 hasConceptScore W2407507636C509974204 @default.
- W2407507636 hasConceptScore W2407507636C71924100 @default.
- W2407507636 hasIssue "4 Suppl 12" @default.
- W2407507636 hasLocation W24075076361 @default.
- W2407507636 hasOpenAccess W2407507636 @default.
- W2407507636 hasPrimaryLocation W24075076361 @default.
- W2407507636 hasRelatedWork W1968075437 @default.
- W2407507636 hasRelatedWork W1968819130 @default.
- W2407507636 hasRelatedWork W2071189140 @default.
- W2407507636 hasRelatedWork W2367074919 @default.
- W2407507636 hasRelatedWork W2368652023 @default.
- W2407507636 hasRelatedWork W2383009386 @default.
- W2407507636 hasRelatedWork W2554093505 @default.
- W2407507636 hasRelatedWork W2796957233 @default.
- W2407507636 hasRelatedWork W3029134543 @default.
- W2407507636 hasRelatedWork W4255814180 @default.
- W2407507636 hasVolume "24" @default.
- W2407507636 isParatext "false" @default.
- W2407507636 isRetracted "false" @default.
- W2407507636 magId "2407507636" @default.
- W2407507636 workType "article" @default.